Windtree Therapeutics, Inc. (WINT) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
WINT Revenue Analysis (2013–2024)
As of March 2, 2026, Windtree Therapeutics, Inc. (WINT) generated trailing twelve-month (TTM) revenue of $90,000. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, WINT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $2.8 million in 2014.
When compared to Healthcare sector peers including UTHR (+10.6% YoY), ZLAB (+15.3% YoY), and AMRN (-6.2% YoY). Compare WINT vs UTHR →
Peer Comparison
Compare WINT's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| WINTCurrent | $90,000 | - | - | - | |
| UTHR | $3.2B | +10.6% | +16.5% | 46.9% | |
| ZLAB | $460M | +15.3% | +56.5% | -49.9% | |
| AMRN | $229M | -6.2% | -11.9% | -40.2% | |
| ALKS | $1.5B | -5.2% | +7.3% | 17.2% | |
| ADMA | $426M | +27.6% | +70.8% | 32.6% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-84,000 | - | $-25,019,000 | - |
| 2023 | $0 | - | $-82,000 | - | $-17,539,000 | - |
| 2022 | $0 | - | $-1,061,000 | - | $-41,333,000 | - |
| 2021 | $0 | - | $-869,000 | - | $-77,280,000 | - |
| 2020 | $0 | -100.0% | $-638,000 | - | $-30,317,000 | - |
| 2019 | $198K | -88.9% | $185K | 93.6% | $-24,893,000 | -12572.2% |
| 2018 | $1.8M | +20.4% | $-8,774,000 | -490.7% | $-16,195,000 | -905.8% |
| 2017 | $1.5M | -27.3% | $-15,891,000 | -1070.1% | $-22,548,000 | -1518.4% |
| 2016 | $2.0M | +106.9% | $1.8M | 87.5% | $-38,036,000 | -1862.7% |
| 2015 | $987K | -65.2% | $58K | 5.9% | $-39,834,000 | -4035.9% |
See WINT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs WINT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare WINT vs AGIO
See how WINT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is WINT's revenue growth accelerating or slowing?
WINT TTM revenue: $90000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is WINT's long-term revenue growth rate?
Windtree Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is WINT's revenue distributed by segment?
WINT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.